T1	Participants 34 73	delusional patients with schizophrenia.
T2	Participants 197 230	delusional schizophrenia patients
T3	Participants 439 587	three subject groups--patients with schizophrenia with prominent delusions, patients with schizophrenia without delusions, and healthy participants.
